3,4-DAP may modulate brain motor activity in patients with MS, probably by enhancing excitatory synaptic transmission.
No takes yet. Share an insight, caveat, or question.
Mainero et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: